Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

33 Best Mid-Cap Stocks To Buy Now: Axis Capital



Axis Capital has conducted an in-depth review of 33 top-quality mid-cap stocks which are quoting at reasonable valuations and which have great potential




Axis Capital has, in its comprehensive research report, pointed that mid-cap stocks have a great potential ahead because they have under-performed the large-caps. A detailed analysis of the strength of 33 mid-cap stocks has been conducted.

The USP of the report is that it goes into great depth over the strengths and weaknesses of the said stocks. It also explains why investors should buy these stocks in preference to other stocks.

Click here for the Axis Capital report on best 33 mid-cap stocks
investments, Mid Cap, Multibagger, Portfolio, Stock Picks   

2 Comments
  1. shiv shukla's Gravatar shiv shukla
    June 7, 2014 at 1:56 am | Permalink

    sir plz sugested top midcap stock

    Reply
  2. sanjeev kumar's Gravatar sanjeev kumar
    March 29, 2015 at 11:44 am | Permalink

    Sir I want to invest 50000Rs for six months. Please suggest me a valuable stock.

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 493 other subscribers

RSS Stocks Talk Forum

  • Shalby is a multi-specialty hospital chain with expertise in joint replacement
    Shalby is a multi-specialty hospital chain with expertise in joint replacement. It is making right strides with calibrated growth based on big ticket expansion in metros & tier I cities & asset-light franchisee expansion in tier II-VI towns. TP ₹310 (35%) Download... Shalby is a multi-specialty hospital chain with expertise in joint replacement
  • DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
    DLF has strong growth prospects due to strong sectoral tailwinds, record low inventory, greater preference for branded luxury, extensive launch pipeline & expansion in its annuity portfolio. Strong Balance Sheet with consistent cash flow. TP ₹1081 (+30%) Research Report... DLF has strong growth prospects. Buy for target price of ₹1081 (30% upside)
  • Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
    Aditya Birla Capital has demonstrated solid performance, achieving strong growth in the loan book while maintaining asset quality. Management has reiterated guidance on both growth & credit cost fronts. Lending business expected to grow at 30%. TP (+37%)... Aditya Birla Capital has demonstrated solid performance. Buy for target price of ₹280 (37% upside)
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!